Mason Morfit ValueAct Holdings
Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
New York Times
NYT
|
+$260M |
| 2 |
BLD
TopBuild
BLD
|
+$63.1M |
| 3 |
Insight Enterprises
NSIT
|
+$28.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLM Corp
SLM
|
+$174M |
| 2 |
Bausch Health
BHC
|
+$120M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$8.46M |
| 4 |
Rocket Companies
RKT
|
+$6.12M |
| 5 |
Trinity Industries
TRN
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.51% |
| 2 | Financials | 27.17% |
| 3 | Real Estate | 10.56% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Communication Services | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FISV
1
Fiserv Inc
FISV
$28B
| $1.37B | 23.22% |
14,647,776
| – | – |
|
2
KKR & Co
KKR
$97.4B
| $1.14B | 19.27% |
26,456,563
| – | – |
|
3
Seagate
STX
$193B
| $715M | 12.12% |
13,437,070
| – | – |
|
4
CBRE Group
CBRE
$44B
| $623M | 10.56% |
9,234,964
| – | – |
|
5
LKQ Corp
LKQ
$6.52B
| $592M | 10.03% |
12,552,751
| – | – |
|
6
Citigroup
C
$221B
| $458M | 7.76% |
10,992,637
| – | – |
|
|
7
Insight Enterprises
NSIT
$4.33B
| $364M | 6.17% |
4,421,951
+322,725
| +8% | +$28.7M |
|
|
8
New York Times
NYT
$10.6B
| $334M | 5.66% |
11,614,741
+8,519,741
| +275% | +$260M |
|
|
BLD
9
DELISTED
TopBuild
BLD
| $255M | 4.32% |
1,546,253
+341,345
| +28% | +$63.1M |
|
|
AMPS
10
DELISTED
Altus Power
AMPS
| $44M | 0.75% |
4,000,020
| – | – |
|
|
11
Rocket Companies
RKT
$39.4B
| $8.19M | 0.14% |
1,296,027
-703,973
| -35% | -$6.12M |
|
|
AMPS.WS
12
DELISTED
Altus Power Warrants
AMPS.WS
| $56K | ﹤0.01% |
18,417
| – | – |
|
|
13
Bausch Health
BHC
$2.41B
| – | – |
-14,341,265
| Closed | -$120M |
|
|
14
SLM Corp
SLM
$4.97B
| – | – |
-10,886,031
| Closed | -$174M |
|
|
15
Trinity Industries
TRN
$2.37B
| – | – |
-90,847
| Closed | -$2.2M |
|
|
UNVR
16
DELISTED
Univar Solutions Inc.
UNVR
| – | – |
-340,000
| Closed | -$8.46M |
|
Similar funds
Mason Morfit's Q3 2022 Portfolio in Review
As of Q3 2022, Mason Morfit held 16 positions worth $5.9B, down 5.9% from $6.27B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mason Morfit's Q3 2022 filing shows 3 increased, 1 reduced and 4 closed positions. The largest sale was SLM Corp, an estimated $174M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 42% a quarter earlier, followed by Financials and Real Estate.
- Mason Morfit added most to New York Times in Q3 2022, an estimated $260M increase.
- Mason Morfit's biggest Q3 2022 reduction was Rocket Companies, cutting an estimated $6.12M.
- Mason Morfit fully exited SLM Corp in Q3 2022, selling an estimated $174M.
- Mason Morfit's ten largest holdings make up 100% of its $5.9B portfolio in Q3 2022.
- Mason Morfit opened 0 new positions and closed 4 in Q3 2022.
- Mason Morfit's portfolio value fell 5.9% quarter-over-quarter to $5.9B.
Based on ValueAct Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.